Phthalylsulfacetamide

Phthalylsulfacetamide (CAS No.: 131-69-1) is a sulfonamide-class antibacterial compound widely utilized as a reference agent in microbiological and pharmacological research, characterized by its ability to inhibit bacterial dihydropteroate synthase and thereby disrupt folate biosynthesis essential for microbial growth and proliferation. As a prodrug-like derivative, it can undergo gradual decomposition under physiological-like conditions to release sulfacetamide, contributing to its antibacterial activity profile. In vitro studies typically demonstrate activity in the low micromolar range, although potency varies depending on the bacterial strain and assay conditions. This compound is commonly employed in cell-based and in vivo experimental systems to investigate antimicrobial efficacy, resistance mechanisms, and pharmacokinetic behavior, as well as to benchmark novel antibacterial candidates during early-stage drug discovery. Experimental concentrations or dosing regimens are determined by specific study designs and endpoints. As with other sulfonamides, careful consideration of potential off-target or adverse biological effects is necessary when interpreting experimental outcomes.